Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression

被引:15
作者
Kuo, Dong-Yih [2 ,3 ]
Chen, Pei-Ni [3 ,4 ]
Yu, Ching-Han [2 ,3 ]
Kuo, Meng-Hsien [5 ]
Hsieh, Yih-Shou [3 ,4 ]
Chu, Shu-Chen [1 ]
机构
[1] Cent Taiwan Univ Sci & Technol, Dept Food Sci, Taichung 406, Taiwan
[2] Chung Shan Med Univ, Dept Physiol, Taichung 40201, Taiwan
[3] Chung Shan Med Univ Hosp, Taichung 40201, Taiwan
[4] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 40201, Taiwan
[5] Natl Taichung Second Senior High Sch, Taichung 404, Taiwan
关键词
NPY-Y1; receptor; MC3R; Appetite; Amphetamine; FOOD-INTAKE; FEEDING-BEHAVIOR; ARCUATE NUCLEUS; GENE-EXPRESSION; PARAVENTRICULAR NUCLEUS; ENERGY HOMEOSTASIS; YY1; RECEPTOR; TREATED RATS; BODY-WEIGHT; NPY;
D O I
10.1016/j.neuropharm.2012.06.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recently, we reported that an initial decrease followed by recovery of food intake was observed during four days of amphetamine (AMPH) treatment and suggested that these changes in response were mediated by changes in neuropeptide Y (NPY) and proopiomelanocortin (POMC). Here we investigated if Y1 receptor (Y1 R) and/or Y5 receptor (Y5R) might be involved in this regulation. Rats were treated daily with AMPH for four days. Changes in the expression levels of Y1 R, Y5R, melanocortin receptor 3 (MC3R), and NPY were assessed and compared. Results showed that Y1R and MC3R increased, with a maximal increase of about 210% on Day 2 but with a restoration to the normal level on Day 4. In contrast, NPY decreased with a biggest reduction of about 45% on Day 2 and the pattern of expression during AMPH treatment was opposite to those of Y1R and MC3R, while the expression of Y5R was not changed. Central inhibitions of NPY formation or Y1R activity modulated the anorectic response of AMPH and the reciprocal regulation of NPY and MC3R, revealing a crucial role of Y1R in this action. It is suggested that Y1R participates in the reciprocal regulation of NPY- and MC3R-containing neurons in the hypothalamus during the anorectic effect of AMPH. These results may further the understanding of Y1R in the control of eating. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:842 / 850
页数:9
相关论文
共 50 条
  • [21] Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity
    Kameda, Minoru
    Kobayashi, Kensuke
    Ito, Hirokatsu
    Miyazoe, Hiroshi
    Tsujino, Toshiaki
    Nakama, Chisato
    Kawamoto, Hiroshi
    Ando, Makoto
    Ito, Sayaka
    Suzuki, Tomoki
    Kanno, Tetsuya
    Tanaka, Takeshi
    Tahara, Yoshio
    Tani, Takeshi
    Tanaka, Sachiko
    Tokita, Shigeru
    Sato, Nagaaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4325 - 4329
  • [22] Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig
    Lecklin, A
    Lundell, I
    Paananen, L
    Wikberg, JES
    Männistö, PT
    Larhammar, D
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (08) : 2029 - 2037
  • [23] Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors
    Taiwo, OB
    Taylor, BK
    PAIN, 2002, 96 (03) : 353 - 363
  • [24] Neuropeptide Y increases differentiation of human olfactory receptor neurons through the Y1 receptor
    Huang, Tsung-Wei
    Li, Sheng-Tien
    Chen, Duan-Yu
    Young, Tai-Horng
    NEUROPEPTIDES, 2019, 78
  • [25] Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation
    Meurs, Alfred
    Portelli, Jeanelle
    Clinckers, Ralph
    Balasubramaniam, Ambikaipakan
    Michotte, Yvette
    Smolders, Ilse
    NEUROSCIENCE LETTERS, 2012, 510 (02) : 143 - 147
  • [26] Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor
    Yang, Chunxiao
    Gong, Zihua
    Zhang, Xiaochen
    Miao, Shuai
    Li, Bozhi
    Xie, Wei
    Wang, Tao
    Han, Xun
    Wang, Liang
    Dong, Zhao
    Yu, Shengyuan
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
  • [27] The Identification of Neuropeptide Y Receptor Subtype Involved in Phenylpropanolamine-induced Increase in Oxidative Stress and Appetite Suppression
    Hsieh, Yih-Shou
    Kuo, Meng-Hsien
    Chen, Pei-Ni
    Kuo, Dong-Yih
    NEUROMOLECULAR MEDICINE, 2013, 15 (01) : 159 - 168
  • [28] Fasting inhibits excitatory synaptic input on paraventricular oxytocin neurons via neuropeptide Y and Y1 receptor, inducing rebound hyperphagia, and weight gain
    Wang, Lei
    Suyama, Shigetomo
    Lee, Samantha A. A.
    Ueta, Yoichi
    Seino, Yutaka
    Sharp, Geoffrey W. G.
    Yada, Toshihiko
    FRONTIERS IN NUTRITION, 2022, 9
  • [29] Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression
    Hsieh, YS
    Hsu, JD
    Yang, SF
    Kuo, DY
    PEPTIDES, 2004, 25 (12) : 2155 - 2161
  • [30] Neuropeptide y selectively potentiates α1-adrenoceptor mediated contraction through Y1 receptor subtype in rat femoral artery
    Tsurumaki, T
    Honglan, P
    Higuchi, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 : S33 - S37